Pott, C., Hoster, E., Delfau-Larue, M., Beldjord, K., Böttcher, S., Asnafi, V., . . . Dreyling, M. (2010). Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: A European MCL intergroup study. American Society of Hematology.
Chicago Style CitationPott, Christiane, et al. Molecular Remission Is an Independent Predictor of Clinical Outcome in Patients With Mantle Cell Lymphoma After Combined Immunochemotherapy: A European MCL Intergroup Study. American Society of Hematology, 2010.
Cita MLAPott, Christiane, et al. Molecular Remission Is an Independent Predictor of Clinical Outcome in Patients With Mantle Cell Lymphoma After Combined Immunochemotherapy: A European MCL Intergroup Study. American Society of Hematology, 2010.